China Universal Asset Management Company’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.6K Buy
12,500
+2,500
+25% +$10.8K ﹤0.01% 459
2026
Q1
$37K Buy
10,000
+5,000
+100% +$21K ﹤0.01% 473
2025
Q4
$17.3K Buy
+5,000
New +$20K ﹤0.01% 489

Other funds holding RCEL

China Universal Asset Management Company's RCEL Position: Q2 2026 in Review

China Universal Asset Management Company increased its Avita Medical (RCEL) stake by 25% in Q2 2026, buying an estimated $10.8K and bringing the position to 12,500 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

China Universal Asset Management Company first reported a position in RCEL in Q4 2025 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • China Universal Asset Management Company held 12,500 shares of Avita Medical worth $51.6K as of Q2 2026.
  • China Universal Asset Management Company bought 2,500 Avita Medical shares in Q2 2026, an estimated $10.8K.
  • Avita Medical made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #459 holding.
  • China Universal Asset Management Company first reported a position in Avita Medical in Q4 2025 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.